2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$38.15-$0.55 (-1.42%)
Price as of Jul 14, 2026 4:50 AM EDT- $8.2BMarket Cap
- 108.18%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$38.15-$0.55 (-1.42%)
IMVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.70 | ||
Change | -$1.01 (-2.54%) | ||
Open | $39.24 | ||
High | $39.34 | ||
Low | $37.53 | ||
Previous Close | $39.71 | ||
Volume | 806,472 | ||
30-Day Average Volume | 1,666,706 | ||
1-Week Change | 0.26% | ||
1-Month Change | 15.11% | ||
1-Year Change | 108.18% | ||
3-Year Change | 90.92% | ||
5-Year Change | 277.19% | ||
Fundamentals | |||
Shares Outstanding | 205.3M | ||
Total Assets | $957.0M | ||
Market Cap | $8.2B | ||
Enterprise Value | $7.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$147.9M | ||
Free Cash Flow | -$95.1M | ||
EBIT | -$150.7M | ||
EBITDA | -$150.6M | ||
Net Working Capital | $844.4M | ||
EPS | -$0.72 | ||
Enterprise Value/EBITDA | -48 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -55 | ||
PEG | 3 | ||
Price/Free Cash Flow | -86 | ||
Price/Operating Cash Flow | -86 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue